Literature DB >> 17823937

Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children.

Johanna Uusimaa1, Jukka S Moilanen, Leena Vainionpää, Päivi Tapanainen, Päivi Lindholm, Matti Nuutinen, Tuija Löppönen, Elina Mäki-Torkko, Heikki Rantala, Kari Majamaa.   

Abstract

OBJECTIVE: We studied the prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children in a defined population in Northern Ostrobothnia, Finland.
METHODS: Children with diagnoses commonly associated with mitochondrial diseases were ascertained. Blood DNA from 522 selected children was analyzed for 3243A>G. Children with the mutation were clinically examined. Information on health history before the age of 18 years was collected from previously identified adult patients with 3243A>G. Mutation segregation analysis in buccal epithelial cells was performed in mothers with 3243A>G and their children whose samples were analyzed anonymously.
RESULTS: Eighteen children were found to harbor 3243A>G in a population of 97,609. A minimum estimate for the prevalence of 3243A>G was 18.4 in 100,000 (95% confidence interval, 10.9-29.1/100,000). Information on health in childhood was obtained from 37 adult patients with 3243A>G. The first clinical manifestations appearing in childhood were sensorineural hearing impairment, short stature or delayed maturation, migraine, learning difficulties, and exercise intolerance. Mutation analysis from 13 mothers with 3243A>G and their 41 children gave a segregation rate of 0.80. The mothers with heteroplasmy greater than 50% tended to have offspring with lower or equal heteroplasmy, whereas the opposite was true for mothers with heteroplasmy less than or equal to 50% (p = 0.0016).
INTERPRETATION: The prevalence of 3243A>G is relatively high in the pediatric population, but the morbidity in children is relatively low. The random genetic drift model may be inappropriate for the transmission of the 3243A>G mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823937     DOI: 10.1002/ana.21196

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

1.  Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Authors:  Valerie Desquiret-Dumas; Naig Gueguen; Magalie Barth; Arnaud Chevrollier; Saege Hancock; Douglas C Wallace; Patrizia Amati-Bonneau; Daniel Henrion; Dominique Bonneau; Pascal Reynier; Vincent Procaccio
Journal:  Biochim Biophys Acta       Date:  2012-01-28

2.  Epithelial cells from oral mucosa: How to cultivate them?

Authors:  F B Russo; G C Pignatari; I R Fernandes; J L R M Dias; P C B Beltrão-Braga
Journal:  Cytotechnology       Date:  2016-01-29       Impact factor: 2.058

3.  [Characteristics of anesthesia in patients with MELAS syndrome: Case report of anesthesia in video-assisted thoracoscopy].

Authors:  A Haas; F Wappler
Journal:  Anaesthesist       Date:  2015-08-28       Impact factor: 1.041

4.  Heterologous Inferential Analysis (HIA) and Other Emerging Concepts: In Understanding Mitochondrial Variation In Pathogenesis: There is no More Low-Hanging Fruit.

Authors:  Antón Vila-Sanjurjo; Paul M Smith; Joanna L Elson
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2020-06-27       Impact factor: 4.797

6.  Sea food consumption for improving cardiac and cerebral manifestations of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  Fulvio A Scorza; Josef Finsterer
Journal:  Ann Transl Med       Date:  2017-09

7.  Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNA.

Authors:  S M Virtanen; M M Lindroos; K Majamaa; P Nuutila; R J Borra; R Parkkola
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-13       Impact factor: 3.825

8.  A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells.

Authors:  Oded Shaham; Nancy G Slate; Olga Goldberger; Qiuwei Xu; Arvind Ramanathan; Amanda L Souza; Clary B Clish; Katherine B Sims; Vamsi K Mootha
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

9.  Overexpressed mitochondrial leucyl-tRNA synthetase suppresses the A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  Hyejeong Park; Edgar Davidson; Michael P King
Journal:  RNA       Date:  2008-09-16       Impact factor: 4.942

Review 10.  The inheritance of pathogenic mitochondrial DNA mutations.

Authors:  L M Cree; D C Samuels; P F Chinnery
Journal:  Biochim Biophys Acta       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.